14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $20.84 $26.05 Thursday, 25th Apr 2024 CORT stock ended at $22.21. This is 1.20% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.32% from a day low at $22.00 to a day high of $22.73.
90 days $20.84 $26.05
52 weeks $20.84 $34.28

Historical Corcept Therapeutics Incorporated prices

Date Open High Low Close Volume
Feb 13, 2024 $23.20 $23.61 $22.53 $23.05 1 875 056
Feb 12, 2024 $23.13 $24.20 $23.03 $23.95 1 386 901
Feb 09, 2024 $22.65 $23.05 $22.56 $23.01 1 161 462
Feb 08, 2024 $22.33 $22.62 $22.13 $22.49 998 956
Feb 07, 2024 $22.03 $22.63 $21.98 $22.26 965 136
Feb 06, 2024 $21.38 $22.06 $21.08 $22.02 1 035 920
Feb 05, 2024 $21.47 $21.99 $21.14 $21.47 1 283 570
Feb 02, 2024 $21.40 $21.76 $20.87 $21.58 1 367 783
Feb 01, 2024 $21.31 $22.38 $20.96 $21.63 2 943 538
Jan 31, 2024 $22.00 $22.00 $21.00 $21.10 1 737 389
Jan 30, 2024 $22.35 $22.37 $21.30 $21.87 2 090 655
Jan 29, 2024 $21.79 $22.33 $21.60 $22.33 2 055 675
Jan 26, 2024 $23.14 $23.32 $21.52 $21.66 2 994 782
Jan 25, 2024 $22.93 $23.16 $22.62 $22.96 1 767 931
Jan 24, 2024 $23.67 $23.67 $22.84 $22.87 1 386 828
Jan 23, 2024 $23.74 $23.80 $23.01 $23.44 1 825 789
Jan 22, 2024 $22.71 $24.30 $22.60 $23.56 3 940 764
Jan 19, 2024 $24.68 $24.68 $24.02 $24.42 3 340 589
Jan 18, 2024 $24.82 $25.14 $24.43 $24.74 1 237 176
Jan 17, 2024 $24.43 $25.35 $24.23 $24.82 1 554 489
Jan 16, 2024 $23.60 $25.47 $23.37 $24.61 2 510 471
Jan 12, 2024 $23.74 $24.06 $23.09 $23.20 1 166 308
Jan 11, 2024 $24.48 $24.48 $23.16 $23.45 1 417 361
Jan 10, 2024 $25.08 $25.09 $23.83 $24.54 2 677 369
Jan 09, 2024 $27.06 $27.10 $24.52 $25.10 2 886 914
Click to get the best stock tips daily for free!

About Corcept Therapeutics Incorporated

Corcept Therapeuticsorporated Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT